Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility.

Abstract

Heterogeneity of embryological origins is a hallmark of vascular smooth muscle cells (SMCs) and may influence the development of vascular disease. Differentiation of human pluripotent stem cells (hPSCs) into developmental origin-specific SMC subtypes remains elusive. Here we describe a chemically defined protocol in which hPSCs were initially induced to form neuroectoderm, lateral plate mesoderm or paraxial mesoderm. These intermediate populations were further differentiated toward SMCs (>80% MYH11(+) and ACTA2(+)), which displayed contractile ability in response to vasoconstrictors and invested perivascular regions in vivo. Derived SMC subtypes recapitulated the unique proliferative and secretory responses to cytokines previously documented in studies using aortic SMCs of distinct origins. Notably, this system predicted increased extracellular matrix degradation by SMCs derived from lateral plate mesoderm, which was confirmed using rat aortic SMCs from corresponding origins. This differentiation approach will have broad applications in modeling origin-dependent disease susceptibility and in developing bioengineered vascular grafts for regenerative medicine.

• Authors: Christine Cheung, Andreia S Bernardo, Matthew W B Trotter, Roger A Pedersen, Sanjay Sinha
• Journal: Nature biotechnology (Nat Biotechnol) Vol. 30 Issue 2 Pg. 165-73 (Jan 15 2012) ISSN: 1546-1696 [Electronic] United States
• PMID: 22252507 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Vasoconstrictor Agents

Topics

• Animals
• Cell Differentiation
• Disease Susceptibility
• Extracellular Matrix (metabolism)
• Humans
• Mesoderm (growth & development)
• Muscle, Smooth, Vascular (embryology, growth & development)
• Neural Plate (growth & development)
• Pluripotent Stem Cells (cytology)
• Rats
• Regenerative Medicine
• Vasoconstrictor Agents (metabolism)